63 related articles for article (PubMed ID: 2947330)
1. Degradation of glycoprotein and collagenous components of the basement membrane: studies with urokinase-type plasminogen activator, alpha-thrombin, and plasmin.
Goldfarb RH; Murano G; Brundage R; Siegal GP; Terranova V; Garbisa S; Liotta LA
Semin Thromb Hemost; 1986 Oct; 12(4):335-6. PubMed ID: 2947330
[No Abstract] [Full Text] [Related]
2. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S
Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354
[TBL] [Abstract][Full Text] [Related]
3. Matrix proteins of basement membrane of intrahepatic bile ducts are degraded in congenital hepatic fibrosis and Caroli's disease.
Yasoshima M; Sato Y; Furubo S; Kizawa K; Sanzen T; Ozaki S; Harada K; Nakanuma Y
J Pathol; 2009 Feb; 217(3):442-51. PubMed ID: 19025978
[TBL] [Abstract][Full Text] [Related]
4. Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases.
Mackay AR; Corbitt RH; Hartzler JL; Thorgeirsson UP
Cancer Res; 1990 Sep; 50(18):5997-6001. PubMed ID: 2144209
[TBL] [Abstract][Full Text] [Related]
5. Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction.
Ogura Y; Matsunaga Y; Nishiyama T; Amano S
Br J Dermatol; 2008 Jul; 159(1):49-60. PubMed ID: 18460030
[TBL] [Abstract][Full Text] [Related]
6. Suppression of type I collagenase expression by antisense RNA in melanoma cells results in reduced synthesis of the urokinase-type plasminogen activator receptor.
Durko M; Brodt P
Biochem Biophys Res Commun; 1998 Jun; 247(2):342-8. PubMed ID: 9642128
[TBL] [Abstract][Full Text] [Related]
7. Detection of the plasmin system in human mammary pathology using immunofluorescence.
Clavel C; Chavanel G; Birembaut P
Cancer Res; 1986 Nov; 46(11):5743-7. PubMed ID: 2428483
[TBL] [Abstract][Full Text] [Related]
8. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-plasminogen interactions: modulation of plasmin generation.
Silverstein RL; Nachman RL
Semin Thromb Hemost; 1987 Jul; 13(3):335-42. PubMed ID: 2961063
[No Abstract] [Full Text] [Related]
10. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation.
Carmeliet P; Moons L; Lijnen R; Baes M; Lemaître V; Tipping P; Drew A; Eeckhout Y; Shapiro S; Lupu F; Collen D
Nat Genet; 1997 Dec; 17(4):439-44. PubMed ID: 9398846
[TBL] [Abstract][Full Text] [Related]
11. Regulation of protease nexin-1 target protease specificity by collagen type IV.
Donovan FM; Vaughan PJ; Cunningham DD
J Biol Chem; 1994 Jun; 269(25):17199-205. PubMed ID: 8006028
[TBL] [Abstract][Full Text] [Related]
12. Binding and activation of plasminogen at the surface of human keratinocytes.
Reinartz J; Batrla R; Boukamp P; Fusenig N; Kramer MD
Exp Cell Res; 1993 Sep; 208(1):197-208. PubMed ID: 8359216
[TBL] [Abstract][Full Text] [Related]
13. The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling.
Behrendt N
Biol Chem; 2004 Feb; 385(2):103-36. PubMed ID: 15101555
[TBL] [Abstract][Full Text] [Related]
14. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
[TBL] [Abstract][Full Text] [Related]
15. High glucose reduces generation of plasmin activity by mesangial cells.
Fisher EJ; McLennan SV; Yue DK; Turtle JR
Microvasc Res; 1997 Mar; 53(2):173-8. PubMed ID: 9143550
[TBL] [Abstract][Full Text] [Related]
16. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
17. Thrombin cleavage of extracellular matrix proteins.
Goldfarb RH; Liotta LA
Ann N Y Acad Sci; 1986; 485():288-92. PubMed ID: 2952037
[No Abstract] [Full Text] [Related]
18. Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering.
Gundersen D; Trân-Thang C; Sordat B; Mourali F; Rüegg C
J Immunol; 1997 Feb; 158(3):1051-60. PubMed ID: 9013942
[TBL] [Abstract][Full Text] [Related]
19. [State of the thrombin-plasmin system in nephrotoxic nephritis treated with heparin, urokinase, and uroplasmin].
Monastyrskiĭ VA; Ambarova LI
Arkh Patol; 1980; 42(1):17-22. PubMed ID: 6445726
[TBL] [Abstract][Full Text] [Related]
20. Plasmin-catalyzed proteolysis in colorectal neoplasia.
Delbaldo C; Cunningham M; Vassalli JD; Sappino AP
Cancer Res; 1995 Oct; 55(20):4688-95. PubMed ID: 7553650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
